Molecular Therapeutics, Inc. (MRx) today announced the formation of Molecular Imaging Products Company (MIP), which will focus on the manufacture and distribution of molecular imaging and related biochemical products to support researchers working in the expanding field of molecular imaging.

“We are excited about the formation of this new business unit, which leverages the knowledge and expertise in the field of molecular imaging at MRx and our subsidiary, Molecular Imaging Research, Inc.” said Dr. Prasad Sunkara, CEO of Molecular Therapeutics, Inc. “The rapidly growing field of molecular imaging...more

Molecular Imaging Research, Inc., a company that provides pre-clinical evaluation of novel anti-cancer agents for cancer research on a contract basis, announces today the appointment of two key executives for the newly formed company. Wilbur R. Leopold, Ph.D., is appointed as president and William L. Elliott, Ph.D. is named as vice president. Both Leopold and Elliott held leading research roles in cancer pharmacology with Pfizer, Inc. (NYSE:PFE) in Ann Arbor, Mich...more